Replies to post #31631 on Biotech Values

[10nisman]

GTCB...

Dew,

Any reason why Pharming and GTCB wouldn't merge? I understand that GTCB may want an amount that Pharming wouldn't or doesn't want to pay, however, one would think a bigger company (Pharming + GTCB) would be able to have cheaper capital funding costs, as well as, some good synergies in the corporate offices (eliminate some of the duplicate costs). I guess I'm on the side of being as efficient as possible and why not put two companies together that would make each other stronger. Not hoping or thinking such a thing will happen. Thank you for all of your posts.

10nis

[urche]

Question on Pharming

Pharming also plans to file for market approval for the C1 inhibitor with the U.S. Food and Drug Administration.

I haven't looked at the Pharming data, but does it meet the standard for FDA approval---usually two controlled trials? In this case, I would think that the double blind randomized criteria could be dropped.

urche